flow trial semaglutide Effects of With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A Prespecified Secondary Analysis 🚨#FLOW: The most anticipated trial

Clinical Trial Results and FDA Approval Semaglutide has undergone extensive clinical testing

Those who achieved good results on Semaglutide but wanted more may find Tirzepatide sufficient

While eating little-to-no carbs may increase your risk of hypertriglyceridemia eating too many can also have a similar effect

Thyroid hormone action and liver disease, a complex interplay

As with any new treatment, its crucial to weigh the benefits against the risks, and this is best done in consultation with a healthcare professional

They also appear to increase the growth of the cells in your pancreas that produce insulin (beta-cells)